Brief: GEN Ilac Q2 Net Profit Up At 490.3 Mln Lira YoY
10/08/2026 06:15
BRIEF-GEN Ilac Q2 Net Profit Up At 490.3 Mln Lira YoY Aug 10 (Reuters) - GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET GENIL.IS:
SAID ON FRIDAY, Q2 NET PROFIT OF 490.3 MLN LIRA VERSUS NET PROFIT OF 102.8 MLN LIRA YEAR AGO
Q2 REVENUE OF 7.0 BLN LIRA VERSUS 5.7 BLN LIRA YEAR AGO
Source text: nIKA8S7pBG
Further company coverage: GENIL.IS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Gen Ilac ve Saglik Urunleri Sanayi Ticaret
See all newsBrief: Gen Ilac Says It Wins Pharmaceutical Tender In Kazakhstan, Expects $1.19 Million Sales Contribution In 2027
Brief: Gen Ilac Says It Participates In Kazakhstan Drug Procurement Tender Via Med Service Plus Authorized By Kazakhstan Representative Office Of Gen Ilac
Brief: Gen Ilac Says It Signs Supply And Distribution Agreement With Incyte On Oct 9
Brief: Gen Ilac Says It Completes Pharmaceutical Manufacturing Plant Investment In Azerbaijan
Brief: Gen Ilac Says It Is To Start Share Buyback Programme For Max 125 Mln Nominal Shares With Allocated Funds Of 1.5 Bln Lira